Mental Health Professionals and Patients Often Disagree on Causes of Symptoms
A new study finds that clinicians’ disregard for mental health patients’ insight into their own condition may be detrimental to treatment.
The Charade of New Drug Approvals for Schizophrenia
The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.
FDA Approves Drugs Faster Than Ever but Relies on Weaker Evidence
From NPR: Almost half of recent new drug approvals were based on only one pivotal clinical trial instead of the two or more that used to be the norm.
